We earn commissions from brands listed on this site, which influences how listings are presented. Advertising Disclosure

Enclomiphene vs TRT: Fertility, Effectiveness, and Cost Compared

Enclomiphene raises your own testosterone and preserves fertility; TRT replaces it and suppresses sperm production. Compare effectiveness, side effects, and monthly costs.

Key Takeaways

Enclomiphene and TRT solve low testosterone from opposite directions: enclomiphene stimulates your own production and preserves fertility, while TRT replaces testosterone externally and suppresses sperm production. Enclomiphene typically raises total testosterone 1.5-2.5x from baseline at $50-$120 per month; TRT reaches any target level reliably at $99-$199 per month. For men under 40 who want children, enclomiphene is usually the right first conversation; for confirmed primary hypogonadism, TRT is the tool that works.

Enclomiphene vs TRT (testosterone) at a Glance

FeatureEnclomipheneTRT (testosterone)
How it worksStimulates your own production via pituitaryReplaces testosterone externally
FertilityPreserved; sperm counts maintainedSuppressed, often severely, within months
Testicular size/functionMaintainedAtrophy common
Typical testosterone increase1.5-2.5x baseline (varies by response)Any target level, reliably
Works for primary hypogonadismNo (requires functioning testes)Yes
FormatDaily oral tabletWeekly injections (typical), gels, other formats
FDA statusOff-label (compounded)FDA-approved products, Schedule III
Telehealth cost$50-$120/month$99-$199/month
StoppingProduction continues (was never shut down)3-6+ month recovery of natural production

About This Comparison

Our Editorial Standards

This testosterone replacement therapy provider comparison is independently researched by our editorial team. We compare telehealth services based on publicly available information including pricing, available treatments, service areas, and verified customer reviews.

Independent Research: We do not accept payment for rankings or favorable reviews
Affiliate Disclosure: We may earn commissions from qualifying purchases at no extra cost to you
Regular Updates: Content is reviewed and updated monthly for accuracy
Licensed Providers Only: All listed services employ US-licensed healthcare providers

Not Medical Advice: This comparison is for informational purposes only. We are not healthcare providers. Always consult with a licensed physician before starting any treatment. Read our full medical disclaimer and editorial policy.

Independent ResearchUnbiased provider comparisons
Fact-Checked InformationVerified against official sources
Regularly UpdatedContent reviewed monthly
Licensed Providers OnlyAll listed services are US-licensed

Enclomiphene vs TRT: Fertility, Effectiveness, and Cost Compared

Tariq HassanWritten by Tariq HassanStaff Writer
10 min read

Enclomiphene and testosterone replacement therapy both treat low testosterone, but through opposite strategies, and the choice between them hinges on one question more than any other: do you want to preserve fertility? TRT delivers testosterone from outside, which reliably raises levels but signals your pituitary to stop producing LH and FSH, shutting down both your natural production and sperm creation within months. Enclomiphene, a selective estrogen receptor modulator taken as a daily tablet, blocks estrogen feedback at the pituitary, increasing LH and FSH output so your testes produce more testosterone themselves, with clinical trials showing total testosterone increases of roughly 1.5-2.5x from baseline while maintaining sperm counts. The tradeoffs run deeper than fertility: enclomiphene only works when your testes can respond (secondary hypogonadism), symptom improvements do not always track the lab numbers, and it remains off-label in the US. This comparison lays out who each approach genuinely serves, what the evidence shows, and the cost math at 2026 telehealth prices.

Stimulation vs Replacement: The Core Difference

Your testosterone production runs on a feedback loop: the hypothalamus and pituitary read circulating hormone levels and adjust LH and FSH output, which tell the testes how much testosterone and sperm to make. TRT floods the loop from outside; the pituitary reads high testosterone, cuts LH and FSH to near zero, and the testes go dormant, which is why testicular shrinkage and infertility are mechanical consequences of standard TRT rather than rare side effects.
Enclomiphene hacks the same loop in the other direction. Estrogen (converted from testosterone) is the main brake signal the pituitary reads; enclomiphene blocks estrogen receptors there, so the pituitary stops sensing the brake and increases LH and FSH. Your testes, now receiving a stronger signal, produce more testosterone and keep making sperm. The catch is built into the mechanism: it only works if your testes can respond. Men with primary hypogonadism, where the testes themselves have failed, get no benefit, which is why diagnosis matters before choosing this path.

Who Each Approach Genuinely Serves

The fork is diagnosis plus fertility priority. Enclomiphene fits men with secondary hypogonadism (a pituitary signaling problem, not testicular failure) who want to raise testosterone while keeping the option of biological children, and men who simply prefer not to shut down their natural production. Younger men with low testosterone, who disproportionately have secondary hypogonadism and active fertility plans, are the core enclomiphene population, which is why fertility-aware clinics reach for it first in that group.
TRT fits men with primary hypogonadism, where the testes cannot respond to any amount of pituitary signaling and replacement is the only option that works; men who are done having children or never wanted them; and men whose symptoms demand a specific, reliably-hit testosterone target that enclomiphene response cannot guarantee. TRT also wins on predictability: you can dose it to land a man at 600 ng/dL on command, while enclomiphene delivers whatever multiple of baseline that individual testes produce, which varies. Neither is universally superior; they serve populations that partly overlap and partly do not.
  • Choose enclomiphene if: you have secondary hypogonadism, want to preserve fertility, are under ~40, or prefer an oral that keeps your own system running.
  • Choose TRT if: you have primary hypogonadism, are done with fertility, need a guaranteed testosterone level, or did not respond to enclomiphene.
  • Diagnosis first: LH and FSH on your labs distinguish primary (high LH/FSH) from secondary (low or normal LH/FSH) hypogonadism and largely decide which tool can even work.
  • Not mutually exclusive over time: some men use enclomiphene during fertility years and transition to TRT later, or use hCG alongside TRT to bridge the gap.

Effectiveness and Side Effects

On raising numbers, both work, but differently. Enclomiphene trials show total testosterone rising roughly 1.5-2.5x from baseline, often moving a man from the 250s into the 500-700 ng/dL range, while LH, FSH, and sperm parameters hold or improve. TRT hits any target the prescriber chooses because the dose is the level. The honest complication with enclomiphene is that symptom relief does not always match the lab improvement: some men see good numbers but modest symptom change, a gap researchers attribute partly to the different estrogen dynamics enclomiphene creates compared to TRT.
Side effect profiles diverge from the mechanisms. Enclomiphene, a SERM, can cause mood changes, headaches, and occasional visual disturbances (a class effect of estrogen-receptor modulators), and because it raises testosterone it can secondarily raise estradiol. TRT carries its own established profile: erythrocytosis (thickened blood requiring hematocrit monitoring), acne, potential sleep apnea worsening, testicular atrophy, and the fertility suppression that is the entire reason enclomiphene exists. TRT as a Schedule III controlled substance also brings stricter prescribing and monitoring requirements, while enclomiphene is prescribed off-label as a compounded medication with lighter regulatory handling but less long-term safety data.

Cost and How to Decide

Enclomiphene runs $50-$120 per month through telehealth clinics as a compounded oral, and TRT runs $99-$199 per month for injectable programs including medication and physician oversight. The price gap is modest and rarely the deciding factor; fertility and diagnosis dominate the decision. Both are cash-pay in most telehealth settings, both are HSA/FSA eligible, and both require ongoing lab monitoring that some subscriptions include and others bill separately.
The decision sequence that works: get diagnosed properly first, because LH and FSH levels determine whether enclomiphene can work at all, and no amount of preference overrides primary hypogonadism. Then weigh fertility honestly, not just for now but for a realistic future, since TRT-induced infertility is not reliably reversible after years of use. If you are a fertility-preserving candidate with secondary hypogonadism, enclomiphene is usually the right first trial, with TRT available if response or symptom relief disappoints. If you have primary hypogonadism or no fertility concerns, TRT is the more predictable tool. For the full TRT picture including formats, monitoring, and clinic selection, read our guide on how online TRT works, and if fertility is your driving concern, raise enclomiphene and hCG explicitly with any clinic before starting testosterone.

Frequently Asked Questions

Is enclomiphene as effective as TRT?

For raising testosterone in the right candidate, it works well, but differently, and "as effective" depends on your goal. Enclomiphene trials show total testosterone rising roughly 1.5-2.5x from baseline, frequently moving men from deficient into the normal 500-700 ng/dL range while preserving fertility. TRT is more predictable because the dose sets the level: a prescriber can target any number reliably, which enclomiphene cannot guarantee since it depends on how your testes respond. The important asterisk is symptom relief, which does not always track the numbers with enclomiphene: some men achieve good lab values but only modest symptom improvement, possibly due to differences in how estrogen behaves on enclomiphene versus TRT. Two hard limits define enclomiphene effectiveness: it does nothing for primary hypogonadism, where the testes cannot respond regardless of signaling, and its long-term safety data is thinner than testosterone therapy has accumulated over decades. For a fertility-preserving man with secondary hypogonadism, it is genuinely effective; for guaranteed levels or primary hypogonadism, TRT is the reliable tool.

Does enclomiphene preserve fertility better than TRT?

Yes, and this is its defining advantage, not a marginal one. TRT suppresses fertility as a mechanical consequence: external testosterone tells your pituitary to stop releasing LH and FSH, the hormones that drive sperm production, and counts fall substantially within months, with some long-term users becoming azoospermic (no sperm at all). Recovery after stopping TRT typically takes 6-18 months and is not guaranteed, especially after years of use. Enclomiphene does the opposite by design: it increases LH and FSH output, so it maintains or even improves sperm production while raising testosterone, which is exactly why fertility-focused clinics choose it for men who want children. If biological fatherhood is on your horizon at all, this difference should dominate your decision, because it is far easier to preserve fertility than to recover it. Men set on TRT who still want the option can preserve function with hCG or enclomiphene alongside testosterone, but that adds cost and complexity that starting with enclomiphene avoids entirely.

Who should not take enclomiphene?

Men with primary hypogonadism are the clearest exclusion: if your testes have failed (shown by high LH and FSH on labs alongside low testosterone), enclomiphene stimulates a system that cannot respond, so it simply will not work, and TRT is the appropriate treatment. That is why LH and FSH testing before choosing matters so much; they distinguish the pituitary-signaling problem enclomiphene fixes from the testicular-failure problem it cannot. Beyond diagnosis, men who need a specific guaranteed testosterone level, for symptom control that has proven dose-sensitive, may find enclomiphene response too variable. Men with certain visual or mood sensitivities should know SERMs can cause visual disturbances and mood changes as class effects. And anyone comparing options should weigh that enclomiphene is used off-label as a compounded medication with less long-term safety data than testosterone therapy, which is not a reason to avoid it but is a reason to have the conversation with a prescriber who knows the tradeoffs rather than a clinic selling one answer to everyone.

Can I switch from TRT to enclomiphene?

Sometimes, and it is a recognized transition, but it is trickier than starting fresh and depends on why you are switching. The common scenarios: a man on TRT decides he wants children and needs to restart his own production and sperm output, or a man wants off exogenous testosterone but still needs support for low levels. Because TRT suppresses your natural axis, coming off it means your own production is dormant, and enclomiphene is one of the tools (often with hCG) used in a restart protocol to wake the pituitary-testis signaling back up. Success is not guaranteed and depends on how long you were on TRT, your age, and your underlying diagnosis: a younger man with secondary hypogonadism who was on TRT briefly has better odds than an older man after years of therapy. This is not a self-managed switch; it requires a prescriber experienced in restart protocols, staged labs to track LH, FSH, testosterone, and sperm recovery, and realistic expectations about timeline, which typically runs months. If fertility is the reason, starting the conversation before years of TRT accumulate makes the switch far more likely to work.

How much does enclomiphene cost compared to TRT?

Enclomiphene runs $50-$120 per month through telehealth clinics as a compounded oral tablet, and injectable TRT programs run $99-$199 per month including medication, supplies, and physician oversight, so enclomiphene is often modestly cheaper but the two overlap and price is rarely the deciding factor. Both are cash-pay in most telehealth settings because insurance treatment differs: TRT can be covered through traditional prescribers with documented hypogonadism, while enclomiphene, being off-label and compounded, is essentially always self-pay. Both are HSA and FSA eligible. Factor in monitoring costs the same way for each: lab panels at $50-$150 if not included in your subscription, needed at baseline and periodically. The honest framing is that fertility preservation and correct diagnosis, not the roughly $50 monthly price difference, should drive this choice, because picking the wrong tool for your hypogonadism type wastes money regardless of which is cheaper. Get LH and FSH tested, weigh your fertility plans, and let the medicine follow the diagnosis.

Sources & References

Our comparisons are informed by official sources and regulatory guidelines. We encourage readers to verify information with authoritative sources.

Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards

Ready to Compare Providers?

See which telehealth providers carry these treatments, at what price, and get started today.

Compare Testosterone Replacement Therapy ProvidersEstimate Your Cost

Related Resources

Article

Best Testosterone Replacement Therapy Providers

Testosterone Replacement Therapy
Article

Treatment Cost Calculator

Medical Disclaimer: This comparison is for informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or changing any medication. Individual results and experiences may vary. Read our full medical disclaimer.